Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Norgestimate
(D05209)		[1] Norgestimate[1] Norgestimate (D05209) 💬[1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 299 💬
2Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg
(D05209)		[3] Estradiol,
Ethinylestradiol,
Norgestimate		[3] Estradiol ,
Ethinyl estradiol ,
Norgestimate (D05209) 💬		[3] ESR1,
ESR2,
PGR 💬		[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 299 💬